{"filing":{"accession_number":"0001104659-26-093042","cik":"0001737953","ticker":"REPL","company_name":"Replimune Group, Inc.","form":"8-K","filing_date":"2026-08-10","report_date":"2026-08-09","primary_document":"tm2622673d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465926093042/tm2622673d1_8k.htm"},"events":[{"id":26378,"run_id":23969,"accession_number":"0001104659-26-093042","anchor_item_number":"8.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"Replimune entered into an underwriting agreement on August 9, 2026, to issue 9,701,490 shares of common stock at $12.06 per share and 2,736,340 pre-funded warrants, generating approximately $150 million in gross proceeds. This is a registered public offering of equity securities that will dilute existing shareholders' ownership and is material to investors assessing the company's capital structure and financing activities.","company_name":"Replimune Group, Inc.","ticker":"REPL","filing_date":"2026-08-10","form":"8-K","submitted_at":null,"items":[{"id":27474,"accession_number":"0001104659-26-093042","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Replimune entered into an underwriting agreement on August 9, 2026, to issue 9,701,490 shares of common stock at $12.06 per share and 2,736,340 pre-funded warrants, generating approximately $150 million in gross proceeds. This is a registered public offering of equity securities that will dilute existing shareholders' ownership and is material to investors assessing the company's capital structure and financing activities.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T11:51:38.852044+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":27474,"accession_number":"0001104659-26-093042","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Replimune entered into an underwriting agreement on August 9, 2026, to issue 9,701,490 shares of common stock at $12.06 per share and 2,736,340 pre-funded warrants, generating approximately $150 million in gross proceeds. This is a registered public offering of equity securities that will dilute existing shareholders' ownership and is material to investors assessing the company's capital structure and financing activities.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-10T11:51:38.852044+00:00","company_name":"Replimune Group, Inc.","ticker":"REPL","filing_date":"2026-08-10"}]}